UpdatesPress Release
RPG Life Sciences transferred its API business to a new subsidiary, RPG Active Pharma, which secured an initial INR 243 Cr from InvAscent.
RPG Life Sciences LimitedRPGLIFE · Filed with the exchange
RPGAP will acquire Actis Generics, aiming to expand manufacturing and product portfolio with total investments up to INR 700 Cr.
No comments yet. Be the first.